These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12407586)

  • 1. Retreatment of patients with chronic hepatitis C.
    Shiffman ML
    Hepatology; 2002 Nov; 36(5 Suppl 1):S128-34. PubMed ID: 12407586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of nonresponsive hepatitis C.
    Bailly F; Ahmed SN; Pradat P; Trepo C
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):379-95. PubMed ID: 20377334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C: retreatment of relapsers. An evidence-based approach.
    Cammà C; Craxì A
    Semin Gastrointest Dis; 2000 Apr; 11(2):115-21. PubMed ID: 10803635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management issues in chronic viral hepatitis: hepatitis C.
    Sievert W
    J Gastroenterol Hepatol; 2002 Apr; 17(4):415-22. PubMed ID: 11982722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for nonresponders and relapsers to initial therapy for hepatitis C.
    Duncan M; Younossi Z
    Cleve Clin J Med; 2003 Sep; 70 Suppl 4():S21-6. PubMed ID: 14558642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated interferon and ribavirin in the retreatment of chronic hepatitis C in Korea.
    Cho HC; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
    Gut Liver; 2013 Sep; 7(5):585-93. PubMed ID: 24073317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C: retreatment and treatment of patients with renal failure.
    Chow WC
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E152-5. PubMed ID: 10921399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?
    Gurusamy KS; Wilson E; Koretz RL; Allen VB; Davidson BR; Burroughs AK; Gluud C
    PLoS One; 2013; 8(12):e83313. PubMed ID: 24349487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retreatment with interferon for chronic hepatitis C after transient response.
    Iyoda K; Yuki N; Kato M; Sugiyasu Y; Komori M; Fujii E; Kakiuchi Y; Kaneko A; Yamamoto K; Kurosawa K; Ikeda M; Masuzawa M
    J Clin Gastroenterol; 2000 Dec; 31(4):297-301. PubMed ID: 11129270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapy for chronic hepatitis C.
    Davis GL
    Gastroenterology; 2000 Feb; 118(2 Suppl 1):S104-14. PubMed ID: 10868901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of hepatitis B and C. Problem situations in chronic HBV and HCV infection].
    Goeser T; Töx U
    Praxis (Bern 1994); 2002 May; 91(22):983-90. PubMed ID: 12094433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naives, nonresponders, relapsers: who is there left to treat?
    Desai AP; Reau N
    Clin Liver Dis; 2011 Aug; 15(3):483-95. PubMed ID: 21867932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in sequences of core region, interferon sensitivity-determining region and interferon and ribavirin resistance-determining region of hepatitis C virus genotype 1 during interferon-alpha and ribavirin therapy, and efficacy of retreatment.
    Kozuka R; Enomoto M; Hai H; Ogawa T; Nakaya M; Hagihara A; Fujii H; Kobayashi S; Iwai S; Morikawa H; Tamori A; Kawada N
    Hepatol Res; 2012 Dec; 42(12):1157-67. PubMed ID: 22672644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic hepatitis C treatment failures: role of consensus interferon.
    Gonzalez SA; Keeffe EB
    Biologics; 2009; 3():141-50. PubMed ID: 19707403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries.
    Boeke CE; Hiebert L; Waked I; Tsertsvadze T; Sharvadze L; Butsashvili M; Zakalashvili M; Naing W; Gupta N; Kateera F; McClure C; Ward JW; Ramers CB
    Clin Infect Dis; 2022 Feb; 74(3):513-516. PubMed ID: 34014252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retreatment of chronic hepatitis C in previous non-responders and relapsers.
    Satoskar R; Jensen DM
    Expert Opin Pharmacother; 2007 Oct; 8(15):2491-503. PubMed ID: 17931085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.